HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotherapy in GRIN2A-negative Landau-Kleffner Syndrome.

AuthorsLaura Siri, Francesca Ragona, Tiziana Granata, Luca Moresco, Amnon Cohen
JournalMinerva pediatrica (Minerva Pediatr) Vol. 72 Issue 2 Pg. 139-141 (04 2020) ISSN: 1827-1715 [Electronic] Italy
PMID32441907 (Publication Type: Case Reports, Letter)
Chemical References
  • Anticonvulsants
  • Immunoglobulins
  • Receptors, N-Methyl-D-Aspartate
  • N-methyl D-aspartate receptor subtype 2A
  • Hydrocortisone
  • Methylprednisolone
Topics
  • Agnosia (drug therapy)
  • Anticonvulsants (therapeutic use)
  • Aphasia (drug therapy)
  • Child
  • Female
  • Humans
  • Hydrocortisone (administration & dosage, therapeutic use)
  • Immunoglobulins (therapeutic use)
  • Landau-Kleffner Syndrome (drug therapy, therapy)
  • Methylprednisolone (administration & dosage, therapeutic use)
  • Receptors, N-Methyl-D-Aspartate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: